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Abstract 23 
MenACWY conjugate vaccination was recently introduced in the UK for adolescents and 24 
young adults to reduce disease due to Neisseria meningitidis group W (MenW). We 25 
conducted a cross-sectional carriage study in first year university students. Despite 71% 26 
MenACWY vaccine coverage, carriage of MenW, but not MenY, rose significantly in 27 
students.  28 
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Neisseria meningitidis causes severe sepsis and meningitis. The main reservoir in most 29 
populations is asymptomatic pharyngeal carriage in older adolescents and young adults [1]. 30 
High carriage rates are particularly evident in semi-closed communities of young adults 31 
where individuals live, work and socialize together, including university student populations 32 
[2]. Meningococcal carriage was previously assessed in university students in the UK in 33 
2009/10 at the University of Nottingham (UoN) when a high prevalence of capsular group Y 34 
(MenY) meningococcal carriage was detected [3]. This high level of MenY carriage was 35 
concomitant with a rise in disease caused by MenY strains in the UK [4]. Since 2009, whilst 36 
MenY disease has plateaued, capsular group W (MenW) disease has steadily increased [5]. 37 
This increase is due to the rapid expansion of hyper-virulent strains belonging to the sequence 38 
type 11 clonal complex (MenW:ST-11) [5]. Based on analysis of whole genome sequence 39 
(WGS) data, isolates from the same MenW:ST-11 lineage, termed the ‘South American/UK 40 
strain’ are also endemic in Chile, Brazil and Argentina [6], and recently reported in Australia 41 
[7]. In response, Public Health England (PHE) introduced MenACWY vaccine in the routine 42 
adolescent school program for 14-15 year olds and first-year university students [8]. A catch-43 
up campaign was used to offer MenACWY vaccine to all 14-18 year olds, with 2015 school 44 
leavers (17-18 years of age) being prioritized. 45 
The rationale for targeting the vaccine at older adolescent and young adults stems 46 
from: i) carriage studies showing that this demographic represents the principal reservoir of 47 
meningococcal carriage and; ii) experience with other polysaccharide conjugate vaccines. 48 
Introduction of the MenC monovalent conjugate vaccines previously reduced carriage 49 
acquisition of MenC strains in adolescents and young adults [9] and there is evidence, albeit 50 
limited, to suggest that the quadrivalent vaccine may have a similar effect on carriage of 51 
MenCWY strains [10, 11]. Reduced carriage in this population should lead to other age 52 
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groups being protected indirectly via herd protection, thus enhancing the public health impact 53 
and cost-effectiveness of this targeted vaccination approach. 54 
To assess current trends in meningococcal strain carriage, and to determine the 55 
immediate effect of the MenACWY vaccine on carriage of MenW/Y strains, we conducted a 56 
cross-sectional study in first-year students at the UoN from registration in September 2015 57 
through to March 2016. MenACWY vaccination coverage in this specific student population 58 
increased from 31% (pre-registration) to ca. 70% (immediately post-registration) due to a 59 
campus-based vaccination campaign targeting ‘freshers’ [12]. We report a significant 60 
increase in carriage of MenW strains in first-year university students in the UK.  61 
 62 
The Study 63 
The study was approved by the Research Ethics Committee at the UoN and written informed 64 
consent was obtained from all participants. Convenience samples of first year students were 65 
recruited in September and November 2015 and March 2016. In September students were 66 
recruited during registration, while in November and March students were recruited in five 67 
dormitories (A-E) with single occupancy rooms. Searches of The UoN Health Service 68 
registration database (EMIS Web software; EMIS Health, Leeds, UK) were performed to 69 
determine vaccination status in registered first-year students on arrival at the UoN and 70 
following the campus-based vaccination campaign. In September, pharyngeal swabs (via 71 
mouth) were obtained immediately prior to eligible students receiving MenACWY vaccine. 72 
All pharyngeal swabs were immediately inoculated onto GC selective agar (Oxoid, 73 
Basingstoke, UK) and incubated at 37°C in air containing 5% CO2. After 24 and 48 hours, 74 
oxidase-positive colonies suggestive of Neisseria spp. were selected and identity was 75 
confirmed by amplification of the meningococcal gene crgA plus ctrA and/or porA as 76 
previously described [13]. PCR-based genogrouping was performed as previously described 77 
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[13, 14]. The Meningococcal Reference Unit, PHE, Manchester, UK performed serogrouping 78 
and serotyping of MenW isolates using dot-blot EIA. Sequence data derived from amplified 79 
porA and fHbp alleles was queried against the PubMLST/Neisseria database 80 
(http://pubmlst.org/neisseria). Chi-square tests for significance were performed by using 81 
STATCALC (Epi Info version 7.2.0.1; Centers for Disease Control and Prevention, Atlanta, 82 
GA, USA). 83 
The September sample of 769 first-year students represented 10.9% of the 7,049 first-84 
year students registered in 2015. Carriage rates increased from 14% in late-September 2015 85 
to 39% by mid-November 2015 and 46% in March 2016 (Table 1). The characteristics of 86 
enrolled students and behavioral risk factors for carriage were similar at the three time-points. 87 
The initial carriage rate of 14% was significantly lower for first-year students in September 88 
2015 than in September 2009 (23.2% [3]; χ2 = 34, 1 df; p<0.00001) suggesting a reduction in 89 
meningococcal carriage in adolescents in UK, possibly due to an alteration in risk factors for 90 
carriage. The MenY carriage rate for incoming students (1.8%) was also lower than that 91 
detected in 2009 (2.9% [3]; χ2
 
= 2.0, 1 df; p = 0.15).  92 
In September 2015, carriage of genogroup capsule null locus (cnl), B, Y and W 93 
strains was 4.2, 3.3, 1.8 and 0.7%, respectively. Notably, a substantial part of the increase in 94 
carriage from September 2015 through March 2016 was the result of a significant increase 95 
(0.7 to 8.0%) in carriage of MenW strains (Table 1). No statistically significant change in the 96 
carriage of MenY strains was detected (Table 1). Of the 50 students colonized with MenW, 97 
36 (72%) had received MenACWY vaccine either before or during registration, which is 98 
consistent with the overall MenACWY coverage in our first-year student cohort. Students 99 
colonized with MenW at the latter two sampling points were distributed across all the five 100 
dormitories, suggesting widespread dissemination, and 21 (91%) of the MenW carriers in the 101 
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last time point (March 2016) had been vaccinated at least 5 months before sampling (Table 102 
2). 103 
Analysis of the genogroup W isolates showed that 47/52 (90%) were serotype 2a 104 
(Table 1) and harbored alleles for factor H binding protein (fHbp) peptide 22 and PorA 105 
P1.5,2, identical to the corresponding alleles harbored by the MenW:ST-11 clone responsible 106 
for the increase in invasive MenW disease in UK [5]. Capsular expression was examined by 107 
serogrouping and 32 (62%) of the MenW isolates expressed the W capsular polysaccharide. 108 
Of the 21 MenW carriers in March 2016 who had been vaccinated at least 5 months before 109 
sampling, 15 (71%) were harboring isolates expressing the W capsule (Table 2).  110 
 111 
Conclusions 112 
We detected a rapid rise in carriage of MenW in a university setting. In comparison, carriage 113 
of MenC in adolescents and young adults in the UK, including in university students, prior to 114 
the introduction of MenC monovalent conjugate vaccines, was rare [9]. The rise in MenW 115 
carriage is most likely due to acquisition within student dormitories or social spaces on 116 
campus, but was unexpected as no such isolates were found in a similar study at the UoN in 117 
2008/09 [15], and only a very limited number in a multi-center carriage study involving six 118 
UK universities in 2010/11 [6, 10].  119 
The increase in MenW carriage among university students is potentially significant, 120 
and merits further monitoring, as it could further contribute to the sustained increase in 121 
MenW disease in the UK. Two cases of MenW disease were reported in unvaccinated 122 
students in Nottingham during 2015-16. Students attending universities exhibit high mobility 123 
and may represent a significant ongoing vehicle for amplification and spread of MenW into 124 
communities throughout UK or beyond with important implications for vaccination policy 125 
and future research.  126 
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Table 1. Characteristics of meningococcal carriage in first-year university students, University of Nottingham, UK, 2015–16* 
   Genogroup 
  Capsule null locus Non-groupablea B Y Wb Non-BYW 
Time 
point 
Carriage 
rate 
No. of 
isolates (% 
carried 
strains) 
% of all 
participants 
(95% CI) 
No. of 
isolates (% 
carried 
strains) 
% of all 
participants 
(95% CI) 
No. of 
isolates (% 
carried 
strains) 
% of all 
participants 
(95% CI) 
No. of 
isolates (% 
carried 
strains) 
% of all 
participants 
(95% CI) 
No. of 
isolates (% 
carried 
strains) 
% of all 
participants 
(95% CI) 
No. of 
isolates (% 
carried 
strains) 
% of all 
participants 
(95% CI) 
SEP 110/769  
(14%) 
32  
(29.1) 
4.2  
(2.8-5.6) 
9  
(8.2) 
1.2 
 (0.4-1.9) 
25  
(22.7) 
3.3  
(2.0-4.5) 
14  
(12.7) 
1.8  
(0.88-2.8) 
5  
(4.5)c 
0.7  
(0.1-1.2) 
25  
(22.7) 
3.3 
 (2.0-4.5) 
NOV 136/353  
(39%) 
32  
(23.5) 
9.1#  
(6.1-12.1) 
9  
(6.6) 
2.5  
(0.9-4.2) 
30  
(22.1) 
8.5#  
(5.6-11.4) 
8  
(5.9) 
2.3  
(0.7-3.8) 
24  
(17.6)d 
6.8#  
(4.2-9.4) 
33  
(24.3) 
9.3#  
(6.3-12.4) 
MAR 133/288 
(46%) 
46  
(34.6) 
16.0#  
(11.7-20.2) 
5  
(3.8) 
1.7  
(0.2-3.2) 
17  
(12.8) 
5.9  
(3.2-8.6) 
11  
(8.3) 
3.8  
(1.6-6.0) 
23  
(17.3)e 
8.0#  
(4.9-11.1) 
31  
(23.3) 
10.8# 
(7.2-14.3) 
*CI = confidence interval 
a Isolates lacking ctrA  
b Overall, of the 52 genogroup W isolates, 47 (90%) were serotype 2a and 32 (62%) expressed serogroup W capsule  
c Of the W:2a isolates, 2/4 (50%) expressed serogroup W capsule 
d Of the W:2a isolates, 12/23 (52%) expressed serogroup W capsule 
e Of the W:2a isolates, 15/20 (75%) expressed serogroup W capsule 
# Significant difference compared to genogroup-specific carriage rate in September (p<0.001) 
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Table 2. MenW carriers in each of five dormitories and their respective MenACWY vaccination status 
 
 
 
Time 
pointa  
MenACWY 
vaccination 
statusb  
Dormitory 
A B C D E Total 
No. 
(%) of 
MenW 
carriers 
No. (%) of 
individuals 
sampled 
No. 
(%) of 
MenW 
carriers 
No. (%) of 
individuals 
sampled 
No. 
(%) of 
MenW 
carriers 
No. (%) of 
individuals 
sampled 
No. 
(%) of 
MenW 
carriers 
No. (%) of 
individuals 
sampled 
No. 
(%) of 
MenW 
carriers 
No. (%) of 
individuals 
sampled 
No. (%) 
of 
MenW 
carriers 
No. (%) of 
individuals 
sampled 
NOV  Vaccinated 3 (50) 45 (69) 4 (80) 50 (78) 2 (50) 52 (68) 3 (75) 43 (57) 4 (80) 67 (93) 16 (67)c 257 (73) 
 Non-vaccinated 3 (50) 18 (28) 1 (20) 12 (19) 2 (50) 24 (31) 1 (25) 31 (41) 1 (20) 5 (7) 8 (33)d 90 (25) 
 Un-assignede 0 2 (3) 0 2 (3) 0 1 (1) 0 1 (1) 0 0 0 6 (2) 
 Total 6 (100) 65 (100) 5 (100) 64 (100) 4 (100) 77 (100) 4 (100) 75 (100) 5 (100) 72 (100) 24 (100) 353 (100) 
              
MAR  Vaccinated 9 (100) 50 (79) 3 (75) 43 (65) 4 (80) 57 (77) 3 (100) 24 (65) 2 (100) 39 (81) 21 (91)f 213 (74) 
 Non-vaccinated 0 13 (21) 1 (25) 23 (35) 1 (20) 17 (23) 0 13 (35) 0 9 (19) 2 (9)g 75 (26) 
 Total 9 (100) 63 (100) 4 (100) 66 (100) 5 (100) 74 (100) 3 (100) 37 (100) 2 (100) 48 (100) 23 (100) 288 (100) 
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a Students at the September 2015 time-point were recruited during registration and are not shown. Of these, 76/769 (10%) were not living in 
dormitories. The carriage rate for this specific group (9.2% [95% CI = 2.7%-15.7%]) was lower compared to those students living in dormitories 
(14.9% [95% CI = 12.2%-17.5%]), but the difference was not statistically significant (p>0.05)  
b Students received MenACWY vaccine prior to or during registration (September 2015) 
c Of these, 8/16 (50%) expressed serogroup W capsular polysaccharide 
d Of these, 5/8 (63%) expressed serogroup W capsular polysaccharide 
e Vaccination history unavailable 
f Of these, 15/21 (71%) expressed serogroup W capsular polysaccharide 
g Of these, 1/2 (50%) expressed serogroup W capsular polysaccharide 
 
